ImmunoTargets and Therapy
Volume 12, 2023 - Issue
Open access
214
Views
0
CrossRef citations to date
0
Altmetric
LETTER
Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
Simmi Wiggins1 Sanofi, 410 Thames Valley Park Dr, Reading, RG6 1PT, UKCorrespondence[email protected]
& Noah A Levit2 Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA
Pages 77-78
|
Received 15 May 2023, Accepted 20 May 2023, Published online: 25 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.